跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24,552 条关于
“Renal & Metabolism”
全部
24,552
临床试验
21,503
药物
193
机构
49
资讯
2,807
去年
AstraZeneca Announces $50 Billion US Investment Plan with Virginia Manufacturing Hub for Weight Management and Metabolic Drugs
9小时前
Roche and Genentech Open Boston Innovation Center Focused on Cardiovascular, Renal and Metabolic Disease
2个月前
AstraZeneca's Wainua Falls Short in Phase III ATTR-CM Study Despite Positive Subgroup Signal
8个月前
AstraZeneca Names Rick Suarez US President to Lead $50 Billion Investment Strategy
8个月前
AstraZeneca Completes NYSE Direct Listing as EU Recommends Imfinzi for Gastric Cancer
去年
Roche Launches Innovation Center at Harvard's Enterprise Research Campus to Advance CVRM Research and AI Applications
去年
Fable Therapeutics Appoints Former AstraZeneca Executive David J. Baker as Chief Scientific Officer
去年
Elinzanetant Mass Balance and Metabolism Characterized in Phase 1 Study
去年
AstraZeneca Reports Strong 2024 Performance with 21% Revenue Growth, Sets Ambitious 2025 Pipeline Goals
去年
Novartis' Fabhalta Demonstrates Sustained Benefits in Phase III Trial for C3 Glomerulopathy
第 1 页,共 281 页
上一页
下一页